315 related articles for article (PubMed ID: 17957210)
1. Cardiac Fabry's disease: an unusual cause of left ventricular hypertrophy.
Nunes JP; Costa O; Faria Mdo S; Almeida PB; Lacerda L
Nat Clin Pract Cardiovasc Med; 2007 Nov; 4(11):630-3. PubMed ID: 17957210
[TBL] [Abstract][Full Text] [Related]
2. An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
Nakao S; Takenaka T; Maeda M; Kodama C; Tanaka A; Tahara M; Yoshida A; Kuriyama M; Hayashibe H; Sakuraba H
N Engl J Med; 1995 Aug; 333(5):288-93. PubMed ID: 7596372
[TBL] [Abstract][Full Text] [Related]
3. An unusual cause of dyspnea.
Jamali AH; Ahmed RM; Stein H
Cardiol Rev; 2004; 12(1):10-4. PubMed ID: 14667257
[TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary involvement in Fabry's disease.
Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
[TBL] [Abstract][Full Text] [Related]
5. [Myocardial disease in inherited disease].
Nakao S
Nihon Rinsho; 2000 Jan; 58(1):200-3. PubMed ID: 10885314
[TBL] [Abstract][Full Text] [Related]
6. Cardiac magnetic resonance imaging in patients with Fabry's disease.
Małek LA; Chojnowska L; Spiewak M; Kłopotowski M; Miśko J; Petryka J; Miłosz B; Ruzyłło W
Kardiol Pol; 2010 Aug; 68(8):929-34. PubMed ID: 20730727
[TBL] [Abstract][Full Text] [Related]
7. [Four cases of Fabry's disease mimicking hypertrophic cardiomyopathy].
Tanaka H; Adachi K; Yamashita Y; Toshima H; Koga Y
J Cardiol; 1988 Sep; 18(3):705-18. PubMed ID: 2977798
[TBL] [Abstract][Full Text] [Related]
8. Is left ventricular hypertrabeculation/ noncompaction a cardiac manifestation of Fabry's disease?
Stöllberger C; Finsterer J; Voigtländer T; Slany J
Z Kardiol; 2003 Nov; 92(11):966-9. PubMed ID: 14634768
[TBL] [Abstract][Full Text] [Related]
9. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
[TBL] [Abstract][Full Text] [Related]
10. [Electrocardiogram in Fabry's disease].
Jastrzebski M; Petkow-Dimitrow P
Kardiol Pol; 2008 Jun; 66(6):688-92; discussion 692-3. PubMed ID: 18626840
[No Abstract] [Full Text] [Related]
11. [Cardiological follow-up in patients with Fabry disease].
Pieruzzi F; Pieroni M; Chimenti C; Frustaci A; Sarais C; Cecchi F;
G Ital Cardiol (Rome); 2010; 11(7-8):566-72. PubMed ID: 21033333
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
[TBL] [Abstract][Full Text] [Related]
13. Cardiac manifestations of Fabry's disease: a story of mother and son.
Moses H; Yarnoz MJ; Guglin M
Congest Heart Fail; 2009; 15(2):93-5. PubMed ID: 19379456
[No Abstract] [Full Text] [Related]
14. [Enzyme replacement therapy in Fabry's disease].
Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
Talbot AS; Lewis NT; Nicholls KM
Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
[TBL] [Abstract][Full Text] [Related]
16. Fabry's disease presenting as ventricular tachycardia and left ventricular 'hypertrophy'.
Joshi SB; Ahmar W; Lee G; Aggarwal A
Eur J Echocardiogr; 2008 Sep; 9(5):697-9. PubMed ID: 18490300
[TBL] [Abstract][Full Text] [Related]
17. Screening for Fabry disease in patients with left ventricular hypertrophy.
Mawatari K; Yasukawa H; Oba T; Nagata T; Togawa T; Tsukimura T; Kyogoku S; Ohshima H; Minami T; Sugi Y; Sakuraba H; Imaizumi T
Int J Cardiol; 2013 Aug; 167(3):1059-61. PubMed ID: 23168011
[No Abstract] [Full Text] [Related]
18. [Echocardiographic findings in a case of Fabry's disease with aortic regurgitation and complete AV block, and in his family members].
Iwase M; Yamauchi K; Maeda M; Aoki T; Yokota M; Hayashi H; Sotobata I
J Cardiol; 1988 Jun; 18(2):589-98. PubMed ID: 3150446
[TBL] [Abstract][Full Text] [Related]
19. Reduction in ECG abnormalities and improvement of regional left ventricular function in a patient with Fabry's disease during enzyme-replacement therapy.
Prinz C; Farr M; Hering D; Horstkotte D; Faber L
Clin Res Cardiol; 2010 Jan; 99(1):53-5. PubMed ID: 19774328
[No Abstract] [Full Text] [Related]
20. Long-term changes in arterial structure and function and left ventricular geometry after enzyme replacement therapy in patients affected with Fabry disease.
Collin C; Briet M; Tran TC; Beaussier H; Benistan K; Bensalah M; Mousseaux E; Froissart M; Bozec E; Laurent S; Boutouyrie P; Germain DP
Eur J Prev Cardiol; 2012 Feb; 19(1):43-54. PubMed ID: 21450622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
